Glycemic Control and Quality of Life Following Cataract Surgery in Patients with Type 2 Diabetes and without Maculopathy

References

• Holmes J, McGill S, Kind P, Bottomley J, Gillam S, Murphy M. Health-related quality of life in type 2 diabetes (TARDIS-2). Value Health. 2000;3(Suppl 1):47–51. doi:10.1046/j.1524-4733.2000.36028.x.
   PubMedGoogle Scholar
• Huang ES, Brown SE, Ewigman BG, Foley EC, Meltzer DO. Patient perceptions of quality of life with diabetes-related complications and treatments. Diabetes Care. 2007;30(10):2478–83. doi:10.2337/dc07-0499.
   PubMed Web of Science ®Google Scholar
• Anderson RJ, Freedland KE, Clouse RE, Lustman PJ. The prevalence of comorbid depression in adults with diabetes: a meta-analysis. Diabetes Care. 2001;24(6):1069–78. doi:10.2337/diacare.24.6.1069.
   PubMed Web of Science ®Google Scholar
• American Diabetes A. Economic costs of diabetes in the U.S. in 2012. Diabetes Care. 2013;36(4):1033–46. doi:10.2337/dc12-2625.
   PubMed Web of Science ®Google Scholar
• Prasad S, Kamath GG, Jones K, Clearkin LG, Phillips RP. Prevalence of blindness and visual impairment in a population of people with diabetes. Eye (Lond). 2001;15(Pt 5):640–43. doi:10.1038/eye.2001.200.
   PubMed Web of Science ®Google Scholar
• Kahloun R, Jelliti B, Zaouali S, Attia S, Ben Yahia S, Resnikoff S; et al. Prevalence and causes of visual impairment in diabetic patients in Tunisia, North Africa. Eye (Lond). 2014;28(8):986–91. doi:10.1038/eye.2014.131.
   PubMed Web of Science ®Google Scholar
• Henricsson M, Tyrberg M, Heijl A, Janzon L. Incidence of blindness and visual impairment in diabetic patients participating in an ophthalmological control and screening programme. Acta Ophthalmol Scand. 1996;74(6):533–38. doi:10.1111/j.1600-0420.1996.tb00729.x.
   PubMedGoogle Scholar
• Pollreisz A, Schmidt-Erfurth U. Diabetic cataract-pathogenesis, epidemiology and treatment. J Ophthalmol. 2010;2010:608751. doi:10.1155/2010/608751.
   PubMed Web of Science ®Google Scholar
• Olafsdottir E, Andersson DK, Stefansson E. The prevalence of cataract in a population with and without type 2 diabetes mellitus. Acta Ophthalmol. 2012;90(4):334–40. doi:10.1111/j.1755-3768.2011.02326.x.
   PubMed Web of Science ®Google Scholar
• Mayberry LS, Osborn CY. Family support, medication adherence, and glycemic control among adults with type 2 diabetes. Diabetes Care. 2012;35(6):1239–45. doi:10.2337/dc11-2103.
   PubMed Web of Science ®Google Scholar
• Garcia-Perez LE, Alvarez M, Dilla T, Gil-Guillen V, Orozco-Beltran D. Adherence to therapies in patients with type 2 diabetes. Diabetes Ther. 2013;4(2):175–94. doi:10.1007/s13300-013-0034-y.
   PubMed Web of Science ®Google Scholar
• Kirkman MS, Briscoe VJ, Clark N, Florez H, Haas LB, Halter JB; et al. Diabetes in older adults. Diabetes Care. 2012;35(12):2650–64. doi:10.2337/dc12-1801.
   PubMed Web of Science ®Google Scholar
• Janssen MF, Lubetkin EI, Sekhobo JP, Pickard AS. The use of the EQ-5D preference-based health status measure in adults with Type 2 diabetes mellitus. Diabet Med. 2011;28(4):395–413. doi:10.1111/j.1464-5491.2010.03136.x.
   PubMed Web of Science ®Google Scholar
• Talbot F, Nouwen A, Gingras J, Belanger A, Audet J. Relations of diabetes intrusiveness and personal control to symptoms of depression among adults with diabetes. Health Psychol. 1999;18(5):537–42. doi:10.1037/0278-6133.18.5.537.
   PubMed Web of Science ®Google Scholar
• Rabin R, De Charro F. EQ-5D: a measure of health status from the EuroQol Group. Ann Med. 2001;33(5):337–43. doi:10.3109/07853890109002087.
   PubMed Web of Science ®Google Scholar
• Talbot F, Nouwen A, Gingras J, Gosselin M, Audet J. The assessment of diabetes-related cognitive and social factors: the Multidimensional Diabetes Questionnaire. J Behav Med. 1997;20(3):291–312. doi:10.1023/A:1025508928696.
   PubMed Web of Science ®Google Scholar
• Guo Y, Logan HL, Glueck DH, Muller KE. Selecting a sample size for studies with repeated measures. BMC Med Res Methodol. 2013;13:100. doi:10.1186/1471-2288-13-100.
   PubMed Web of Science ®Google Scholar
• McCrae RR, Kurtz JE, Yamagata S, Terracciano A. Internal consistency, retest reliability, and their implications for personality scale validity. Pers Soc Psychol Rev. 2011;15(1):28–50. doi:10.1177/1088868310366253.
   PubMed Web of Science ®Google Scholar
• Kim YG, Min SH, Hahn S, Oh TJ, Park KS, Cho YM. Efficacy and safety of the addition of a dipeptidyl peptidase-4 inhibitor to insulin therapy in patients with type 2 diabetes: a systematic review and meta-analysis. Diabetes Res Clin Pract. 2016;116:86–95. doi:10.1016/j.diabres.2016.03.011.
   PubMed Web of Science ®Google Scholar
• Chen YY, Lin YJ, Chong E, Chen PC, Chao TF, Chen SA; et al. The impact of diabetes mellitus and corresponding HbA1c levels on the future risks of cardiovascular disease and mortality: a representative cohort study in Taiwan. PLoS One. 2015;10(4):e0123116. doi:10.1371/journal.pone.0123116.
   PubMed Web of Science ®Google Scholar
• Javadi MA, Zarei-Ghanavati S. Cataracts in diabetic patients: a review article. J Ophthalmic Vis Res. 2008;3(1):52–65.
   PubMedGoogle Scholar
• Pollack A, Leiba H, Bukelman A, Oliver M. Cystoid macular oedema following cataract extraction in patients with diabetes. Br J Ophthalmol. 1992;76(4):221–24. doi:10.1136/bjo.76.4.221.
   PubMed Web of Science ®Google Scholar
• Schatz H, Atienza D, McDonald HR, Johnson RN. Severe diabetic retinopathy after cataract surgery. Am J Ophthalmol. 1994;117(3):314–21. doi:10.1016/S0002-9394(14)73138-1.
   PubMed Web of Science ®Google Scholar
• Cheung N, Mitchell P, Wong TY. Diabetic retinopathy. Lancet. 2010;376(9735):124–36. doi:10.1016/S0140-6736(09)62124-3.
   PubMed Web of Science ®Google Scholar
• Chew EY, Benson WE, Remaley NA, Lindley AA, Burton TC, Csaky K; et al. Results after lens extraction in patients with diabetic retinopathy: early treatment diabetic retinopathy study report number 25. Arch Ophthalmol. 1999;117(12):1600–06. doi:10.1001/archopht.117.12.1600.
   PubMedGoogle Scholar